PSK warns Kenyans against dangerous cetirizine misuse driven by social media trend
PSK President Wairimu Njuki
A viral online claim that a common allergy tablet can tighten the vagina has prompted Kenya’s pharmaceutical body to issue an urgent public health warning — and urge women who have already tried it to seek immediate medical attention.
By Yvonne Wambui
A widely available allergy medication is at the centre of a dangerous social media health trend in Kenya, prompting the Pharmaceutical Society of Kenya to issue an urgent public warning yesterday against the misuse of cetirizine tablets.
The trend, which has circulated rapidly on social media platforms, encourages women to insert cetirizine tablets vaginally, with claims that the drug reduces natural moisture and creates a tightening effect during sexual activity. Health professionals have dismissed those claims outright — and warned that the practice carries serious risks.
PSK President Wairimu Njuki clarified that cetirizine is an antihistamine formulated to treat allergic reactions including sneezing, itchy eyes, running noses and skin conditions such as hives. It is designed to be swallowed. It has never been approved, tested or recommended for vaginal use, and no credible medical evidence supports the claims being shared online.
The society was equally direct in addressing a fundamental misconception driving the trend. Vaginal dryness and vaginal tightening are not the same thing. Reducing natural lubrication does not strengthen vaginal muscles or alter the anatomy of the reproductive system. What it does do is increase friction during sexual activity, raising the likelihood of discomfort, irritation and injury to sensitive vaginal tissue — consequences that are as predictable as they are preventable.
Women who have already used cetirizine in this manner have been urged to stop immediately and seek medical attention if they experience any pain, burning sensations, itching, unusual discharge, bleeding or fever. Early professional intervention matters.
The warning arrives against a broader backdrop of concern about social media’s growing influence over health decisions in Kenya, particularly among younger women who increasingly turn to online platforms for medical guidance. The speed at which unverified health claims travel — and the confidence with which they are shared — has created a genuine public health challenge that professional bodies are struggling to keep pace with.
The consequences of this particular trend extend beyond individual health. PSK has flagged reports of surging demand for cetirizine across pharmacy outlets, with rising prices and shortages already emerging in some areas. Patients who legitimately depend on the medication to manage allergic conditions risk being unable to access it — a harm that ripples outward from a trend that was never medically sound to begin with. Pharmacies have been urged to maintain ethical pricing and ensure genuine patients are not disadvantaged.
The public has been advised to purchase medicines only from premises licensed by the Pharmacy and Poisons Board, where registered pharmacists can provide qualified, evidence-based guidance. Healthcare professionals, content creators and social media users have been called upon to exercise responsibility before amplifying health-related claims to large audiences.
The availability of a medicine, PSK stressed, does not make it suitable for every purpose. That principle sounds obvious. Yesterday’s warning is a reminder of how urgently it still needs to be said.
Similar Posts by The Mt Kenya Times:
- Kalonzo marches through Raila country, stones and all
- KRA hits KSh1 trillion early as tax growth surges
- Kalonzo storms Raila’s heartland under stones and teargas — and dares Ruto to stop him
- Matiang’i and Orengo step in as Ukombozi chiefs
- DTB tightens Northern Kenya footprint with Isiolo branch opening, targets 100th branch by year-end
About the Author
